ClinicalTrials.Veeva

Menu

Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS Patients

I

Istanbul University - Cerrahpasa (IUC)

Status

Withdrawn

Conditions

Ventilation Perfusion Mismatch
Respiratory Distress Syndrome, Adult
Covid19
Pulmonary Edema

Treatments

Device: Pulmonary Vascular Permeability Index
Device: Extravascular Lung Water Index

Study type

Observational

Funder types

Other

Identifiers

NCT04508933
0308202247

Details and patient eligibility

About

Covid-19 also primarily affects endothelium that line up the alveoli. The resulting hypoxemia may differ from "typical" Acute Respiratory Distress Syndrome (ARDS) due to maldistribution of perfusion related to the ventilation. Thus, pathophysiology of Covid-19 ARDS is different, which requires different interventions than typical ARDS. The investigators will assess whether extravascular lung water index and permeability of the alveolar capillary differs from typical ARDS with transpulmonary thermodilution (TPTD) technique. Extravascular Lung Water Index (EVLWI) and Pulmonary Vascular Permeability Index (PVPI) will be compared.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ARDS defined by Berlin Criteria longer than 24 hours
  • Undergoing mechanical ventilation
  • Noradrenaline demand >0.1 mcg/kg/min

Exclusion criteria

  • Not meeting ARDS criteria
  • Noninvasive mechanical ventilation
  • ARDS resolved shorter than 24 hours
  • Shock resolved

Trial design

0 participants in 2 patient groups

Typical ARDS
Description:
ARDS due to non Covid19 causes
Treatment:
Device: Extravascular Lung Water Index
Device: Pulmonary Vascular Permeability Index
C-ARDS
Description:
ARDS due to Covid19
Treatment:
Device: Extravascular Lung Water Index
Device: Pulmonary Vascular Permeability Index

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems